Place of baroreceptor activation therapy in the treatment of resistant hypertension  

作　　者：Gian Paolo Rossi Matteo Azzolini 

机构地区：[1]Clinica dell’Ipertensione Arteriosa, Department of Medicine-DIMED, University of Padua

出　　处：《World Journal of Hypertension》2016年第1期36-40,共5页世界高血压杂志

基　　金：Supported by FORICA(The Foundation for Advanced Research in Hypertension and Cardiovascular diseases);the University of Padua(to GPR);HORIZON 2020;COST-ADMIRE

摘　　要：This mini review describes the development of the therapeutic concept of baroreceptor stimulation over the last fifty years alongside the more recent introduction of it for the treatment of drug- resistant hypertension. The pros and cons of this strategy of treatment over renal sympathetic denervation are also discussed in the light of the results of the studies done in the last decade.This mini review describes the development of the therapeutic concept of baroreceptor stimulation over the last fifty years alongside the more recent introduction of it for the treatment of drug- resistant hypertension. The pros and cons of this strategy of treatment over renal sympathetic denervation are also discussed in the light of the results of the studies done in the last decade.

关 键 词：Resistant hypertension TREATMENT BARORECEPTOR STIMULATION RENAL DENERVATION 

分 类 号：R[医药卫生]